Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Classification of Mild Cognitive Impairment With Multimodal Data Using Both Labeled and Unlabeled Samples.

IEEE/ACM transactions on computational biology and bioinformatics - 1 Jan 2000

Yuan Shaoxun, Li Haitao, Wu Jiansheng, Sun Xiao

Abstract excerpt

Mild Cognitive Impairment (MCI) is a preclinical stage of Alzheimer's Disease (AD) and is clinical heterogeneity. The classification of MCI is crucial for the early diagnosis and treatment of AD. In this study, we investigated the potential of using both labeled and unlabeled samples from the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort to classify MCI through the multimodal co-training method. We...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Aged, 80 and over
Share to Algorithms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Alzheimer Disease

Share to Cognitive Dysfunction

Share to Databases, Factual

Share to Diagnosis, Computer-Assisted

Share to Magnetic Resonance Imaging

Source

Identifiers

PMID: 33471765
DOI: 10.1109/TCBB.2021.3053061

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Classification of Mild Cognitive Impairment With Multimodal Data Using Both Labeled and Unlabeled Samples.PMID 33471765Read ↗

Pathogeny Detection for Mild Cognitive Impairment via Weighted Evolutionary Random Forest With Brain Imaging and Genetic DataSemantic proximity Read ↗

Genetic, structural and functional imaging biomarkers for early detection of conversion from MCI to AD.Semantic proximity Read ↗

Molecular Subtyping of Mild Cognitive Impairment based on Genetic Polymorphism and Gene ExpressionSemantic proximity Read ↗

Predictive classification of Alzheimer's disease using brain imaging and genetic data.Semantic proximity Read ↗

Risk Score Stratification of Alzheimer’s Disease and Mild Cognitive Impairment using Deep LearningSemantic proximity Read ↗

Multimodal Imaging and Logistic Weighted Cognitive Scores for Classification of MCI, AD, and FTD SubtypesSemantic proximity Read ↗

Standardized Comparison of Clinical, Cognitive, Genetic, Neuroimaging, and Fluid Biomarkers for Predicting 24-Month Progression from Mild Cognitive Impairment to Alzheimer’s DiseaseSemantic proximity Read ↗

Weakly Supervised Learning for Alzheimer’s Disease Diagnosis Using MRI and Clinical DataSemantic proximity Read ↗

MRI-Based Multi-Class Relevance Vector Machine Classification of Neurodegenerative DiseasesSemantic proximity Read ↗

Identification of Mild Cognitive Impairment Subtypes Predicting Conversion to Alzheimer’s Disease Using a Heterogeneous Mixture LearningSemantic proximity Read ↗

A Novel Ensemble-Based Machine Learning Algorithm To Predict The Conversion From Mild Cognitive Impairment To Alzheimer’s Disease Using Socio-demographic Characteristics, Clinical Information And Neuropsychological MeasuresSemantic proximity Read ↗

Interpretable MRI-Based Deep Learning for Alzheimer’s Risk and ProgressionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.